Abbott developing quicker test for orthopedic infections (press release)
Infection poses one of the most serious risks to patients getting a hip or knee replaced, and a major U.S. drugmaker is developing a test to quickly identify the pathogens responsible so doctors can treat problems sooner.
Abbott Diagnostics Group, a unit of Abbott Laboratories, is working with privately held Genetics Laboratory Inc, whose expertise is in orthopedics, to develop the test.
It will be based on Abbott's PLEX-ID system for identifying microbes, and is expected to help doctors detect infections that become root...
